AmerisourceBergen Corporation (Holding Co)s in-depth stock price analysis indicates that the stock price has rallied 15.1% in the past 12 Weeks , but analyzing the 6 month charts for the stock , the price continues to stay positive and keep the rally at 6.32% . Looking at the past 52 week period, the stock price is up at 6.49% . Relative price strength is a important factor used by wealth management firms while investing in stocks since the indicator compares the stock performance with the overall market. The relative price strength of AmerisourceBergen Corporation (Holding Co) has a negative value of -9.66 compared to overall market performance. AmerisourceBergen Corporation (Holding Co) (NYSE:ABC) has climbed 2.12% in the past week and advanced 7.74% in the last 4 weeks. In the past week, the company has outperformed the S&P 500 by 1.29% and the outperformance has advanced to 5.81% for the last 4 weeks period.
AmerisourceBergen Corporation (Holding Co) (NYSE:ABC) stock ended Friday session in the red zone in a volatile trading. The stock closed down 0.48 points or 0.52% at $91.17 with 1,527,574 shares getting traded. Post opening the session at $91.54, the shares hit an intraday low of $90.266 and an intraday high of $91.75 and the price was in this range throughout the day. The company has a market cap of $19,809 million and the number of outstanding shares has been calculated to be 217,279,690 shares. The 52-week high of AmerisourceBergen Corporation (Holding Co) (NYSE:ABC) is $92.48 and the 52-week low is $68.38.
AmerisourceBergen Corp. Last issued its quarterly earnings results on Jan 31, 2017. The company reported $1.36 EPS for the quarter, beating the analyst consensus estimate by $ 0.13. Analyst had a consensus of $1.23. The company had revenue of $38169.30 million for the quarter, compared to analysts expectations of $39009.35 million. The companys revenue was up 4.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.27 EPS.
Several Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock.AmerisourceBergen Corp. was Upgraded by Leerink Partners to Outperform on Jan 17, 2017. AmerisourceBergen Corp. was Upgraded by BofA/Merrill to Buy on Jan 12, 2017. AmerisourceBergen Corp. was Downgraded by Mizuho on Jan 3, 2017 to Neutral, Price Target of the shares are set at $83.
Company has reported several Insider transactions to the SEC, on Feb 2, 2017, Steven H Collis (Chairman, President & CEO) sold 15,000 shares at 87.15 per share price.On Sep 22, 2016, Henry Wadsworth Iii Mcgee (director) sold 3,351 shares at 82.10 per share price.On Sep 8, 2016, Kathy H. Gaddes (Executive Vice President) sold 681 shares at 88.15 per share price.
AmerisourceBergen Corporation provides pharmaceutical services. It distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers. The Company also provides pharmacy services to certain specialty drug patients. AmerisourceBergen Corporation is based in Chesterbrook, Pennsylvania.